• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Apollo Medical Holdings, Inc. Appoints Jeremy R. Jackson, M.D., as Chief of Staff

    3/2/21 8:05:00 AM ET
    $AMEH
    Professional Services
    Consumer Discretionary
    Get the next $AMEH alert in real time by email

    ALHAMBRA, Calif., March 2, 2021 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare management company, today announced the appointment of Jeremy R. Jackson, M.D., to the newly created role of Chief of Staff, effective March 10, 2021.

    In his role as Chief of Staff, Dr. Jackson will work closely with the executive team and play a key role in special projects for ApolloMed's technology platform, business development, strategy and operations.

    Dr. Jackson brings 10 years of healthcare industry experience in management consulting and as a practicing physician to ApolloMed. He previously served as a Project Leader in the Boston Consulting Group's healthcare practice and, from 2011 to 2018, was a resident physician in the Department of General Surgery at Brigham and Women's Hospital (Harvard Medical School) where he led the postoperative care teams serving patients across a broad spectrum of surgical disease. Dr. Jackson was also a Chief Resident in Quality and Patient Safety for the Department of Surgery at the Boston Veterans Affairs Hospital from 2017 to 2018 and a research fellow in the Department of Pediatric Surgery at the Children's Hospital Los Angeles from 2014 to 2016. Dr. Jackson received his Doctor of Medicine from the University of Michigan Medical School and Bachelor of Arts in Biological Sciences, Magna Cum Laude, from the University of Southern California.

    Kenneth Sim, M.D., Executive Chairman and Co-Chief Executive Officer of ApolloMed, stated, "We are thrilled to welcome Jeremy to the ApolloMed leadership team at this exciting time in the Company's history. Jeremy's prior experience as a practicing physician and as a strategy consultant to various companies within the healthcare space made him the ideal person to take on the Chief of Staff role. He is familiar with the challenges facing today's healthcare providers and will play a key role in ensuring the Company is prioritizing and working on our initiatives effectively, which is particularly important given our aggressive growth strategy."

    Dr. Jackson added, "I am pleased to be joining ApolloMed, one of the leading providers of integrated value-based care management and delivery in the country. I believe the Company has developed a unique physician-centric model that, combined with the proprietary technologies built and implemented over the past couple of years, make it truly stand out from its peers. I look forward to making my contributions to ApolloMed's efforts as we continue to focus on cost effectively ensuring positive health outcomes and experiences for our patients."

    About Apollo Medical Holdings, Inc.
    ApolloMed is a leading physician-centric, technology-powered, risk-bearing healthcare management company. Leveraging its proprietary population health management and healthcare delivery platform, ApolloMed operates an integrated, value-based healthcare model, which aims to empower the providers in its network to deliver the highest quality of care to its patients in a cost-effective manner.

    Headquartered in Alhambra, California, ApolloMed's subsidiaries include management services organizations ("MSOs"), affiliated independent practice associations ("IPAs") and a Next Generation Accountable Care Organization ("NGACO"). Network Medical Management, Inc. and Apollo Medical Management, Inc. are the administrative and managerial services companies for the affiliated physician owned professional corporations that contract with independent physicians to deliver medical services in-office and virtually under the Allied Pacific of California IPA, Alpha Care Medical Group, Inc. and Accountable Health Care IPA brands. These affiliates are supported by ApolloMed Hospitalists, a Medical Corporation. Our NGACO operates under the APA ACO, Inc. brand and participates in the Centers for Medicare & Medicaid Services program that allows provider groups to assume higher levels of financial risk and potentially achieve a higher reward from participation in the program's attribution-based risk sharing model. For more information, please visit www.apollomed.net.

    Forward Looking Statements
    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, such as statements about the Company's continued growth, operational focus and strategic growth plans. Forward-looking statements reflect current views with respect to future events and financial performance and therefore cannot be guaranteed. Such statements are based on the current expectations and certain assumptions of the Company's management, and some or all of such expectations and assumptions may not materialize or may vary significantly from actual results. Actual results may also vary materially from forward-looking statements due to risks, uncertainties and other factors, known and unknown, including the risk factors described from time to time in the Company's reports to the SEC, including, without limitation the risk factors discussed in the Company's Annual Report on Form 10-K for the year ended December 31, 2019, filed with the SEC and any subsequent quarterly reports on Form 10-Q.

    FOR MORE INFORMATION, PLEASE CONTACT:
    Investor Relations
    (626) 943-6491
    [email protected]

    Carolyne Sohn, The Equity Group
    (415) 568-2255
    [email protected]

    SOURCE Apollo Medical Holdings, Inc.

    Related Links

    http://apollomed.net

    Get the next $AMEH alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $AMEH

    DatePrice TargetRatingAnalyst
    2/22/2024$44.00 → $55.00Neutral → Buy
    BofA Securities
    1/24/2024$45.00Buy
    Stifel
    12/22/2023$41.00Hold
    Truist
    10/17/2023$45.00Buy
    BTIG Research
    4/12/2023$44.00Neutral
    BofA Securities
    12/19/2022$40.00Buy
    Lake Street
    9/21/2022Outperform
    William Blair
    1/11/2022$93.00Buy
    Colliers Securities
    More analyst ratings

    $AMEH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Apollo Medical Holdings, Inc. Becomes Astrana Health, Inc.

      ALHAMBRA, Calif., Feb. 22, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc.("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, announced today it will formally change its name from Apollo Medical Holdings, Inc. ("ApolloMed") to Astrana Health, Inc. ("Astrana Health"). As previously announced, the Company will begin trading under the ticker symbol "ASTH." Both changes will take effect February 26, 2024.

      2/22/24 8:00:00 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • Apollo Medical Holdings, Inc. Schedules 2023 Fourth Quarter and Full Year Financial Results Release and Conference Call

      ALHAMBRA, Calif., Jan. 31, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the fourth quarter and full year ended December 31, 2023, after the close of the stock market on Tuesday, February 27, 2024. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.

      1/31/24 8:00:00 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • ApolloMed and BASS Medical Group to Forge a Value-Based Healthcare Partnership

      ALHAMBRA, Calif., Jan. 29, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc.("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced a strategic long-term partnership with BASS Medical Group, one of the largest multi-specialty medical groups in the Greater San Francisco Bay Area. The partnership will bolster BASS Medical Group's value-based care and operational infra

      1/29/24 8:00:00 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary

    $AMEH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Apollo Medical upgraded by BofA Securities with a new price target

      BofA Securities upgraded Apollo Medical from Neutral to Buy and set a new price target of $55.00 from $44.00 previously

      2/22/24 9:10:05 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • Stifel initiated coverage on Apollo Medical with a new price target

      Stifel initiated coverage of Apollo Medical with a rating of Buy and set a new price target of $45.00

      1/24/24 6:57:05 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • Truist initiated coverage on Apollo Medical with a new price target

      Truist initiated coverage of Apollo Medical with a rating of Hold and set a new price target of $41.00

      12/22/23 7:19:49 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary

    $AMEH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $AMEH
    SEC Filings

    See more
    • Kumar Dinesh M. was granted 150,395 shares (SEC Form 4)

      4 - Apollo Medical Holdings, Inc. (0001083446) (Issuer)

      1/24/24 4:31:15 PM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • SEC Form 3 filed by new insider Kumar Dinesh M.

      3 - Apollo Medical Holdings, Inc. (0001083446) (Issuer)

      1/24/24 4:30:18 PM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • Vong John was granted 14,352 shares, increasing direct ownership by 293% to 19,253 units (SEC Form 4)

      4 - Apollo Medical Holdings, Inc. (0001083446) (Issuer)

      12/19/23 9:10:18 PM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • Apollo Medical Holdings Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits

      8-K - Astrana Health, Inc. (0001083446) (Filer)

      2/29/24 6:03:30 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • Apollo Medical Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Astrana Health, Inc. (0001083446) (Filer)

      2/27/24 4:19:15 PM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • Apollo Medical Holdings Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

      8-K - Astrana Health, Inc. (0001083446) (Filer)

      2/26/24 6:04:01 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary

    $AMEH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Apollo Medical Holdings Inc. (Amendment)

      SC 13G/A - Apollo Medical Holdings, Inc. (0001083446) (Subject)

      2/13/24 4:58:57 PM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • SEC Form SC 13D/A filed by Apollo Medical Holdings Inc. (Amendment)

      SC 13D/A - Apollo Medical Holdings, Inc. (0001083446) (Subject)

      11/17/23 4:15:14 PM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Apollo Medical Holdings Inc. (Amendment)

      SC 13G/A - Apollo Medical Holdings, Inc. (0001083446) (Subject)

      2/9/23 11:07:39 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary

    $AMEH
    Financials

    Live finance-specific insights

    See more
    • Apollo Medical Holdings, Inc. Schedules 2023 Fourth Quarter and Full Year Financial Results Release and Conference Call

      ALHAMBRA, Calif., Jan. 31, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the fourth quarter and full year ended December 31, 2023, after the close of the stock market on Tuesday, February 27, 2024. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.

      1/31/24 8:00:00 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • Apollo Medical Holdings, Inc. Reports Second Quarter 2023 Results

      Company to Host Conference Call on Monday, August 7, 2023, at 2:30 p.m. PT/5:30 p.m. ET ALHAMBRA, Calif., Aug. 7, 2023 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced its consolidated financial results for the second quarter ended June 30, 2023. Brandon Sim, Co-Chief Executive Officer of ApolloMed, stated, "Our strong

      8/7/23 5:17:00 PM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • Apollo Medical Holdings, Inc. Schedules 2023 Second Quarter Financial Results Release and Conference Call

      ALHAMBRA, Calif., July 28, 2023 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that it will release financial results for the second quarter ended June 30, 2023, after the close of the stock market on Monday, August 7, 2023. The Company will discuss those results in a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.

      7/28/23 8:05:00 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary

    $AMEH
    Leadership Updates

    Live Leadership Updates

    See more
    • ApolloMed and BASS Medical Group to Forge a Value-Based Healthcare Partnership

      ALHAMBRA, Calif., Jan. 29, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc.("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced a strategic long-term partnership with BASS Medical Group, one of the largest multi-specialty medical groups in the Greater San Francisco Bay Area. The partnership will bolster BASS Medical Group's value-based care and operational infra

      1/29/24 8:00:00 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • Akido Appoints Eric Chin as its first Chief Financial Officer As the Company Prepares to Accelerate Growth

      LOS ANGELES, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Akido, a tech-integrated medical network reimagining healthcare from the ground up, announced that Eric Chin has been appointed Chief Financial Officer, effective immediately. Chin will work closely with Akido's co-founders as the company continues to bring its unique blend of AI-powered technology, best-in-class medical services and scalable preventive care programs to new markets across the U.S. Previously, Chin served as Chief Financial Officer at Apollo Medical Holdings (ApolloMed), a publicly traded physician-centric technology-powered healthcare company (NASDAQ:AMEH) that increased reported total revenue from approximately $520 million i

      1/31/23 9:30:00 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • The Oncology Institute Names Mihir Shah as Chief Financial Officer

      CERRITOS, Calif., April 04, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (NASDAQ:TOI) today announced the appointment of Mihir Shah as chief financial officer, effective immediately. In this role, Mr. Shah will lead the Accounting, Finance, Revenue Cycle Management, and Investor Relations functions, playing a key role in driving TOI's public company success and executing the strategic growth plan. Mr. Shah succeeds Scott Dalgleish, who will serve as a senior advisor through a transition period. Mr. Shah joins TOI with fifteen years of industry leadership experience across public, private, and not-for-profit organizations. Most recently Mr. Shah served as chief fi

      4/4/22 6:01:00 AM ET
      $AMEH
      $TOI
      Professional Services
      Consumer Discretionary
      Medical/Nursing Services
      Health Care